Skip to main content
logo
PT Prodia Diagnostic Line Tbk (IDX:PRDL)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
107.00
-1.00 (-0.93%)
Last updated: Nov 4, 2026, 2:59 PM WIB

IDX:PRDL Financials Overview

Millions IDR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Revenue
40,86874,37158,656111,779
Revenue Growth
-30.33%26.79%-47.52%-
Gross Profit
12,94543,01530,93773,565
Operating Income
-4,36424,77615,00148,251
Net Income
-7,81516,9899,99835,776
Earnings Per Share
-3.1113.938.1929.32
EPS Growth
-69.93%-72.05%-

Revenue by Segment
Chart
Fiscal Year
FY 2025FY 2024FY 2023
Period EndingDec '25 Dec '24 Dec '23
Clinical Chemistry
60,38150,59293,989
Hematology
4,0861,06293.03
Instrument
8,8266,89316,532
Immunology & Biomoleculer
56.5725.59962.88
Services
1,02283.3202
Total
74,37158,656111,779

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Cash & Investments
21,76110,80329,45828,659
Total Debt
60,57994,300102,40848,767
Net Cash (Debt)
-38,818-83,497-72,951-20,108
Net Cash Growth
----
Net Cash Per Share
-15.43-68.44-59.80-16.48

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-61.6121,787-3,96231,797
Capital Expenditures
-16,599-30,576-49,288-49,144
Free Cash Flow
-16,661-8,789-53,249-17,347
Free Cash Flow Growth
----

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Gross Margin
31.67%57.84%52.74%65.81%
Operating Margin
-10.68%33.31%25.57%43.17%
Pretax Margin
-15.41%30.28%22.82%42.17%
Profit Margin
-19.12%22.84%17.04%32.01%
FCF Margin
-40.77%-11.82%-90.78%-15.52%